LP120 POLYPEPTIDES AND THERAPEUTIC USES THEREOF

The present invention relates to the identification and isolation of novel DNA, therapeutic uses and the recombinant production of novel polypeptides cloned from a normalized human bone marrow cDNA library, designated herein as LP120 polypeptides. The present invention also relates to vectors, host...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FU, DONG-JING, BASINSKI, MARGRET, BARBARA, MILLS, BRADLEY, JAY, ROSTECK, PAUL, ROBERT, JR, SANKHAVARAM, PATANJALI, RAGHAVACH
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to the identification and isolation of novel DNA, therapeutic uses and the recombinant production of novel polypeptides cloned from a normalized human bone marrow cDNA library, designated herein as LP120 polypeptides. The present invention also relates to vectors, host cells, and antibodies directed to LP120 polypeptides. L'invention concerne l'identification et l'isolation d'un nouvel ADN, les utilisations thérapeutiques et la préparation par recombinaison de nouveaux polypeptides clonés à partir d'une banque d'ADNc normalisée de moelle osseuse humaine, désignés polypeptides LP120. Elle concerne également des vecteurs, des cellules hôtes et des anticorps relatifs à ces polypeptides LP120.